NDC 0067-2030

NDC 0067-2030

NDC 0067-2030 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 0067-2030
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 0067-2030-50 [00067203050]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-06 [00067203006]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-02 [00067203002]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-77 [00067203077]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-92 [00067203092]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-94 [00067203094]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-10 [00067203010]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-09-27
Marketing End Date2013-06-21

NDC 0067-2030-83 [00067203083]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-33 [00067203033]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-91 [00067203091]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-24 [00067203024]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-57 [00067203057]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-08 [00067203008]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-51 [00067203051]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-30 [00067203030]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

NDC 0067-2030-07 [00067203007]

Excedrin Extra Strength TABLET, FILM COATED
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2006-09-27
Marketing End Date2014-12-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.